Australia's Starpharma jumps as nasal spray shows antiviral activity against Omicron

Starpharma Holdings

01/03/2022 02:58

** Shares of Starpharma Holdings Ltd  SPL.AX  jumps as much
as 8% to A$0.950, gaining the most since Dec 2021
    ** Biopharma co the antiviral agent in VIRALEZE, antiviral
nasal spray, showed potent antiviral activity against Omicron
variant  urn:newsml:reuters.com:*:nFWN2V3225
    ** Co says, the agent achieved more than 99.5% reduction of
virus infectivity against the variant 
    ** As of last close, Stock is down 34.33% this year    


 (Reporting by Navya Mittal in Bengaluru)
 ((navya.mittal@thomsonreuters.com))